FINHUB Insights

TMO · Q2 FY26 · Mar 29 – Jun 27, 2026

Thermo Fisher Scientific Q2 FY26: where the revenue came from and where it went

Thermo Fisher Scientific Q2 FY26: revenue $12.0B (+10% year over year). Net profit $1.7B. Largest cohort Services $5.2B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 29 – Jun 27, 2026
Reported
Jul 31, 2026 10-Q
Sankey diagram of Thermo Fisher Scientific's income statement for Q2 FY26: revenue of $11.99 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$11.99B +10% year over year
Gross profit$4.75B 40% margin
Operating profit$2.09B 17% margin
Net profit$1.74B 14% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 27, 2026).
ItemValueShare of revenueYear over year
Revenue 11.99 100% +10%
Services 5.17 43% +12%
Product consumables 5.07 42% +10%
Product instruments 1.75 15% +6%
Cost of revenue−7.2460%
Gross profit4.7540% margin+0pp
R&D−0.363%+0pp
SG&A−2.3019%+0pp
Operating profit2.0917% margin+1pp
Tax−0.17
Interest & other costs−0.18
Net profit1.7414%+0pp
Filing on EDGAR More quarters of TMO

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters